540 related articles for article (PubMed ID: 8548582)
21. Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter.
Tanaka S; Iwai M; Harada Y; Morikawa T; Muramatsu A; Mori T; Okanoue T; Kashima K; Maruyama-Tabata H; Hirai H; Satoh E; Imanishi J; Mazda O
Cancer Gene Ther; 2000 Sep; 7(9):1241-50. PubMed ID: 11023196
[TBL] [Abstract][Full Text] [Related]
22. A Renilla luciferase-Aequorea GFP (ruc-gfp) fusion gene construct permits real-time detection of promoter activation by exogenously administered mifepristone in vivo.
Yu YA; Szalay AA
Mol Genet Genomics; 2002 Oct; 268(2):169-78. PubMed ID: 12395191
[TBL] [Abstract][Full Text] [Related]
23. Sustained expression after nonviral ocular gene transfer using mammalian promoters.
Kachi S; Esumi N; Zack DJ; Campochiaro PA
Gene Ther; 2006 May; 13(9):798-804. PubMed ID: 16467860
[TBL] [Abstract][Full Text] [Related]
24. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters.
Majumdar AS; Hughes DE; Lichtsteiner SP; Wang Z; Lebkowski JS; Vasserot AP
Gene Ther; 2001 Apr; 8(7):568-78. PubMed ID: 11319624
[TBL] [Abstract][Full Text] [Related]
25. Time course of gene expression after plasmid DNA gene transfer to the liver.
Herweijer H; Zhang G; Subbotin VM; Budker V; Williams P; Wolff JA
J Gene Med; 2001; 3(3):280-91. PubMed ID: 11437333
[TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo gene delivery mediated by a synthetic polycationic amino polymer.
Goldman CK; Soroceanu L; Smith N; Gillespie GY; Shaw W; Burgess S; Bilbao G; Curiel DT
Nat Biotechnol; 1997 May; 15(5):462-6. PubMed ID: 9131627
[TBL] [Abstract][Full Text] [Related]
27. The mechanism of naked DNA uptake and expression.
Wolff JA; Budker V
Adv Genet; 2005; 54():3-20. PubMed ID: 16096005
[TBL] [Abstract][Full Text] [Related]
28. Bacterial magnetic particles (BMPs)-PEI as a novel and efficient non-viral gene delivery system.
Xiang L; Bin W; Huali J; Wei J; Jiesheng T; Feng G; Ying L
J Gene Med; 2007 Aug; 9(8):679-90. PubMed ID: 17605136
[TBL] [Abstract][Full Text] [Related]
29. Comparative analysis of inducible expression systems in transient transfection studies.
Meyer-Ficca ML; Meyer RG; Kaiser H; Brack AR; Kandolf R; Küpper JH
Anal Biochem; 2004 Nov; 334(1):9-19. PubMed ID: 15464949
[TBL] [Abstract][Full Text] [Related]
30. A sustained, cytoplasmic transgene expression system delivered by cationic liposomes.
Gao X; Jaffurs D; Robbins PD; Huang L
Biochem Biophys Res Commun; 1994 May; 200(3):1201-6. PubMed ID: 8185568
[TBL] [Abstract][Full Text] [Related]
31. Systemic genetic transfer of p21WAF-1 and GM-CSF utilizing of a novel oligopeptide-based EGF receptor targeting polyplex.
Liu X; Tian PK; Ju DW; Zhang MH; Yao M; Cao XT; Gu JR
Cancer Gene Ther; 2003 Jul; 10(7):529-39. PubMed ID: 12833133
[TBL] [Abstract][Full Text] [Related]
32. Intracellular production of DNA enzyme by a novel single-stranded DNA expression vector.
Chen Y; McMicken HW
Gene Ther; 2003 Sep; 10(20):1776-80. PubMed ID: 12939644
[TBL] [Abstract][Full Text] [Related]
33. Pegylated immuno-lipopolyplexes: A novel non-viral gene delivery system for liver cancer therapy.
Hu Y; Li K; Wang L; Yin S; Zhang Z; Zhang Y
J Control Release; 2010 May; 144(1):75-81. PubMed ID: 20144670
[TBL] [Abstract][Full Text] [Related]
34. Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system.
Nishikawa M; Yamauchi M; Morimoto K; Ishida E; Takakura Y; Hashida M
Gene Ther; 2000 Apr; 7(7):548-55. PubMed ID: 10819569
[TBL] [Abstract][Full Text] [Related]
35. Heat-directed gene targeting of adenoviral vectors to tumor cells.
Brade AM; Ngo D; Szmitko P; Li PX; Liu FF; Klamut HJ
Cancer Gene Ther; 2000 Dec; 7(12):1566-74. PubMed ID: 11228535
[TBL] [Abstract][Full Text] [Related]
36. Intraperitoneal gene delivery mediated by a novel cationic liposome in a peritoneal disseminated ovarian cancer model.
Lee MJ; Cho SS; You JR; Lee Y; Kang BD; Choi JS; Park JW; Suh YL; Kim JA; Kim DK; Park JS
Gene Ther; 2002 Jul; 9(13):859-66. PubMed ID: 12080380
[TBL] [Abstract][Full Text] [Related]
37. Successful immunogene therapy using colon cancer cells (colon 26) transfected with plasmid vector containing mature interleukin-18 cDNA and the Igkappa leader sequence.
Yoshimura K; Hazama S; Iizuka N; Yoshino S; Yamamoto K; Muraguchi M; Ohmoto Y; Noma T; Oka M
Cancer Gene Ther; 2001 Jan; 8(1):9-16. PubMed ID: 11219497
[TBL] [Abstract][Full Text] [Related]
38. In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats.
Zhang Y; Boado RJ; Pardridge WM
J Gene Med; 2003 Dec; 5(12):1039-45. PubMed ID: 14661179
[TBL] [Abstract][Full Text] [Related]
39. Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein.
Zhang J; Frolov I; Russell SJ
J Gene Med; 2004 Oct; 6(10):1082-91. PubMed ID: 15368589
[TBL] [Abstract][Full Text] [Related]
40. Midkine promoter-based adenoviral vector gene delivery for pediatric solid tumors.
Adachi Y; Reynolds PN; Yamamoto M; Grizzle WE; Overturf K; Matsubara S; Muramatsu T; Curiel DT
Cancer Res; 2000 Aug; 60(16):4305-10. PubMed ID: 10969765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
